iih glp 1 The effect of GLP-1 agonist on idiopathic intracranial hypertension: a systematic review and meta-analysis Idiopathic Intracranial Hypertension and the

Yancik 2005)

The sublingual absorption of Oxithion also eases the administration of glutathione in people with difficulty swallowing and increases the bioavailability of the active ingredient

"We ask the question, do we need to change the dose

TL;DR: In a large sample of US Veterans, GLP-1 drugs were associated with reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions, but increased risk of gastrointestinal issues, hypotension (low blood pressure), and some kidney-related conditions